Irrgeher, Johanna http://orcid.org/0000-0003-3192-0101
Berger, Thomas http://orcid.org/0000-0001-7486-1450
Tchaikovsky, Anastassiya http://orcid.org/0000-0002-7811-3019
Tschegg, Cornelius http://orcid.org/0000-0003-0169-2195
Gouya, Ghazaleh http://orcid.org/0000-0002-7947-1707
Lechner, Peter http://orcid.org/0000-0003-0906-3027
Retzmann, Anika http://orcid.org/0000-0002-0208-5453
Opper, Christine http://orcid.org/0000-0003-0739-9619
Firbas, Christa http://orcid.org/0000-0003-1927-4936
Freissmuth, Michael http://orcid.org/0000-0001-9398-1765
Peschel-Credner, Kerstin
Anderle, Karolina http://orcid.org/0000-0002-2572-9995
Meisslitzer, Claudia
Wolzt, Michael http://orcid.org/0000-0001-6049-1890
Prohaska, Thomas http://orcid.org/0000-0001-9367-8141
Funding for this research was provided by:
Montanuniversität Leoben
Article History
Received: 12 June 2022
Revised: 23 August 2022
Accepted: 29 August 2022
First Online: 22 September 2022
Declarations
:
: Refer to clinicaltrials.gov identifier: NCT04138693 for details of approval.
: The funder had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.Financial interests: JI, AR, CO and TP have fully been employed by Montanuniversität Leoben (MUL). MUL has received research funding from Glock Health Science and Research GmbH in the double-blinded study. JI, AR, CO and TP declare no financial interests.Non-financial interests: JI, AR, CO and TP declare no non-financial interests.Financial interests: TB, AT, CT and CM have fully been employed by the funder Glock Health Science and Research GmbH. The funder had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.Non-financial interests: The authors declare no non-financial interests.Financial interests: MF, MW and KA were fully employed by the Center of Physiology and Pharmacology, Medical University of Vienna, which received research funding by Glock Health Science and Research GmbH.Non-financial interests: MF was on the board of scientific advisors of the Gaston H. Glock Research Laboratories for Exploratory Drug Development at the time the study was carried out. KA and MW declare no non-financial interests.Financial interests: CF was fully funded by the Department of Clinical Pharmacology, Medical University of Vienna. In her role, she was responsible for the clinical trial. CF declares no financial interests.Non-financial interests: CF declares no non-financial interests.Financial interests: GG and PL are self-employed with Gouya Insights and LGS-INSIGHTS, respectively, and were responsible for coordination, planning and statistical evaluation of the study. Both companies received research funding from Glock Health Science and Research GmbH.Non-financial interests: The authors declare no non-financial interests.Financial interests: KPC has been fully employed at Gouya Insights. She declares no financial interest.Non-financial interests: KPC declares no non-financial interests.